Best GLP-1 Medications for Weight Loss in Women 2024

Author: Try Amie Editorial Team | Medical Review: Dr. Sarah Mitchell, MD, FACOG

You've counted the calories. You've tried the programs. You've moved your body, cut the sugar, done the thing — and the scale barely budged. If that sounds familiar, you're not alone, and you're definitely not failing. For millions of women, the gap between effort and results has a biological explanation — and GLP-1 medications are finally offering a clinically backed way to close it.

The buzz around GLP-1 medications is loud right now, and for good reason. These drugs represent a genuine shift in how medicine approaches weight management — not through stimulants or willpower, but through your body's own hormonal signaling. But with multiple options on the market, confusing brand names, and a flood of information (some good, much questionable), figuring out which GLP-1 medication is actually best for you takes more than a quick scroll.

That's what this article is for. We're going to walk through the best GLP-1 medications for weight loss in 2024 — honestly, specifically, and with women's biology front and center.

Here's what we'll cover:

• The top GLP-1 medications ranked for women in 2024
• How they compare on effectiveness, dosing, side effects, and access
• What makes women's weight loss biology uniquely different
• A direct semaglutide vs. tirzepatide comparison
• How to get started with a GLP-1 prescription through telehealth

If you want the full foundation first, start with our complete guide to GLP-1 medications. Otherwise, let's get into the ranking.

What Are GLP-1 Medications and How Do They Work?

The science behind GLP-1 receptor agonists

GLP-1 stands for glucagon-like peptide-1 — a hormone your gut naturally releases after you eat. Its job is to tell your brain you're satisfied, slow down digestion so you stay full longer, and help regulate blood sugar by improving insulin response.

GLP-1 receptor agonist medications mimic this hormone, but at higher, more consistent levels than your body produces on its own. The result is a three-pronged effect:

• Slower gastric emptying — food stays in your stomach longer, so you feel full after smaller portions
• Reduced appetite signaling in the brain — the "food noise" that drives cravings and overeating gets quieter
• Improved insulin sensitivity and blood sugar control — which matters more than most people realize for fat storage and energy

This mechanism is fundamentally different from stimulant-based diet pills that spike your heart rate or suppress appetite through the central nervous system. GLP-1s work with your hormonal biology, not against it. For a deeper comparison, read our breakdown of how GLP-1 differs from traditional diet pills.

Why GLP-1s are a category shift, not just another weight loss drug

Several GLP-1 medications now carry FDA approval specifically for chronic weight management — a classification the FDA doesn't hand out lightly. The clinical trial data behind these approvals is substantial. The STEP trial program (studying semaglutide) and the SURMOUNT trial program (studying tirzepatide) both demonstrated body weight reductions that no previous non-surgical intervention had achieved in randomized controlled settings.

These are prescription medications that require medical supervision, dose titration, and ongoing clinical monitoring. They're not supplements, and they're not something you should order from an unvetted source online. That distinction matters — both for safety and for results.

Why Women's Weight Loss Is Biologically Different

Hormones, metabolism, and the female body

Women's bodies store and burn fat differently than men's — and that's not a motivational talking point, it's endocrinology. Estrogen directs fat storage toward the hips, thighs, and lower abdomen. Progesterone influences water retention and bloating. And across each menstrual cycle phase, levels of leptin (your satiety hormone) and ghrelin (your hunger hormone) fluctuate, creating appetite patterns that have nothing to do with discipline.

Women also tend to have lower basal metabolic rates than men of comparable size, which means slower initial weight loss results — even in clinical trials of the same medications. This doesn't mean the medications work less well for women. It means women need realistic expectations and a care team that understands their biology.

The perimenopause and menopause weight factor

After 40, declining estrogen levels trigger a shift in fat distribution — away from subcutaneous (under-the-skin) fat and toward visceral fat, the metabolically dangerous kind that wraps around your organs. According to the North American Menopause Society's published research, this hormonal transition is directly linked to increased abdominal adiposity, insulin resistance, and cardiovascular risk — independent of caloric intake.

This is why caloric restriction alone becomes a losing strategy during perimenopause and menopause. Your body is responding to hormonal signals, not just calories in and calories out.

For women dealing with perimenopause or menopause symptoms alongside a weight loss journey, hormonal disruptions like hot flashes, sleep disturbances, and mood shifts can make consistency harder. Amie's Grace supplement was designed to support hormonal balance during this transition — a complementary piece of the wellness puzzle for some women.

Why GLP-1s may be particularly relevant for hormonally-driven weight

Emerging research has identified GLP-1 receptors in ovarian tissue and other hormonally active areas of the body, though this science is still early. What's better established is the practical benefit: GLP-1 medications directly address appetite dysregulation and insulin resistance — two of the primary metabolic drivers of weight gain during hormonal transitions.

The Best GLP-1 Medications for Weight Loss in 2024 — Ranked and Compared

Not all GLP-1s are identical. They differ in mechanism, dosing frequency, average effectiveness, side effect profiles, and — critically — how accessible they actually are. Here's an honest breakdown of the top GLP-1 drugs women are using in 2024, what the data says, and what to realistically expect from each.

1. Semaglutide (Ozempic® / Wegovy® / Compounded)

Overview: Semaglutide is a GLP-1 receptor agonist administered as a once-weekly subcutaneous injection. Ozempic® was originally approved for type 2 diabetes management; Wegovy® received FDA approval specifically for chronic weight management in 2021. Compounded semaglutide — prepared by licensed 503A or 503B pharmacies — offers a more accessible option available through qualified telehealth providers like Amie.

Effectiveness: According to the STEP 1 trial published in the New England Journal of Medicine, participants receiving semaglutide 2.4mg weekly lost an average of approximately 14.9% of their body weight over 68 weeks, compared to 2.4% in the placebo group. The appetite suppression effect was consistent and compounded over time with weekly dosing.

Dosing: Semaglutide follows a gradual titration schedule — starting at a low dose (typically 0.25mg/week) and increasing over several months to minimize gastrointestinal side effects. The maintenance dose for weight management (Wegovy) is 2.4mg/week. Compounded formulations may vary. For the full titration walkthrough, see our guide on how semaglutide dosing works.

Side effects (women-specific context):

• Nausea — the most commonly reported side effect, typically peaking during dose increases and improving over weeks
• Constipation and fatigue — reported more frequently by women in clinical and real-world settings
• Hair thinning (telogen effluvium) — a temporary condition linked to rapid weight loss, not the medication itself, but worth knowing about proactively

Access & cost: Brand-name Wegovy carries a list price of approximately $1,300/month without insurance, and supply shortages have been persistent since 2022. Compounded semaglutide is significantly more accessible through licensed telehealth prescribers — both in terms of cost and availability.

For the full deep-dive, read everything you need to know about semaglutide.

2. Tirzepatide (Mounjaro® / Zepbound®)

Overview: Tirzepatide is a dual GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptor agonist — a meaningfully different mechanism from semaglutide. It targets two complementary hormonal pathways simultaneously. Mounjaro® is approved for type 2 diabetes; Zepbound® received FDA approval for chronic weight management in November 2023.

Effectiveness: According to the SURMOUNT-1 trial published in the New England Journal of Medicine, participants on the highest dose of tirzepatide (15mg) achieved an average body weight reduction of approximately 20.9% over 72 weeks. This currently represents the highest efficacy data in the GLP-1 medication class. Tirzepatide may particularly benefit women with significant insulin resistance, as the dual-agonist mechanism directly targets glucose metabolism through two pathways.

Dosing: Weekly subcutaneous injection, titrated from 2.5mg up to a maximum of 15mg. Zepbound availability has been improving but remains limited in some regions.

For a deeper explanation of the dual-agonist mechanism, read our article on how tirzepatide works differently.

Side effects: The gastrointestinal side effect profile is similar to semaglutide — nausea, diarrhea, and constipation are the most common. Some women in real-world use report slightly less nausea compared to semaglutide, though head-to-head tolerability data is limited. Medical supervision during titration remains essential.

Access & cost: Zepbound's list price is comparable to Wegovy. Insurance coverage varies widely. Compounded tirzepatide availability is evolving — FDA regulatory guidance on compounded tirzepatide has shifted during 2024, and the legal status of compounded versions requires careful, up-to-date review.

3. Liraglutide (Saxenda®)

Overview: Liraglutide is an earlier-generation GLP-1 receptor agonist that requires daily injection — a meaningful practical difference from the weekly dosing of semaglutide and tirzepatide. FDA-approved for weight management under the brand name Saxenda®, liraglutide has a lower efficacy ceiling, with clinical trial data showing average weight loss of approximately 5–8% of body weight.

Honest assessment: For most women starting GLP-1 therapy in 2024, semaglutide or tirzepatide will deliver stronger outcomes with more convenient dosing. Liraglutide still has a clinical role for women who experience tolerability issues with newer agents, or who prefer a medication with a longer post-market safety track record. It's not the wrong choice — it's a more modest one.

Quick comparison: top GLP-1 drugs at a glance

Semaglutide vs. Tirzepatide — The Head-to-Head Women Need to See

This is the comparison driving most of the conversation right now — and understandably so. Both are weekly injections with strong clinical data, but they're not interchangeable. Here's what the prescription comparison actually looks like.

What the data actually shows

As of mid-2024, no large-scale direct head-to-head randomized controlled trial comparing semaglutide and tirzepatide for weight loss had been published. The comparison we can draw is indirect — STEP 1 (semaglutide, ~14.9% weight loss) versus SURMOUNT-1 (tirzepatide at 15mg, ~20.9% weight loss). These trials had different participant populations, slightly different designs, and different durations.

The takeaway: tirzepatide's efficacy numbers are higher on paper. But indirect trial comparison is not the same as a direct head-to-head, and real-world outcomes depend heavily on individual factors — your starting weight, metabolic health, hormonal status, medication tolerance, and consistency.

Higher average efficacy in a clinical trial doesn't automatically mean "better for you." A medication you can access, tolerate, and stay on long-term will always outperform one you can't.

A women-centered decision framework

Semaglutide may be the right starting point if you:

• Are trying a GLP-1 medication for the first time
• Want the most extensively studied option with the longest safety track record in this class
• Need accessible pricing — compounded semaglutide through a provider like Amie is often significantly less expensive than brand-name alternatives
• Value convenience of telehealth-based prescribing and delivery

Tirzepatide may be worth discussing with your clinician if you:

• Have a higher BMI (≥35) and want to maximize weight loss percentage
• Have documented insulin resistance or prediabetes alongside weight concerns
• Tried semaglutide and plateaued or experienced tolerability issues
• Have access through insurance or can manage the brand-name cost

Beyond the Prescription — What Makes GLP-1 Therapy Work Long-Term

A GLP-1 prescription is a powerful starting point, not a finish line. The women who see the most sustainable results are the ones who pair medication with intentional lifestyle support. Here's what that looks like in practice.

GLP-1s are a tool — and tools work best with a plan

Protein intake matters more on a GLP-1 than ever. Because these medications reduce appetite significantly, total food intake drops — and without conscious effort, protein intake often drops with it. This accelerates lean muscle loss, which can slow metabolism and undermine long-term body composition goals.

Strength training — even two to three sessions per week — helps preserve muscle during active weight loss. Sleep quality directly affects hunger hormones and recovery. These aren't bonus add-ons; they're core pillars of a GLP-1 protocol that actually works.

Some women combine GLP-1 therapy with Amie's Sermorelin protocol — a growth hormone-releasing peptide that supports lean muscle preservation, recovery, and body composition during weight loss. This is a conversation worth having with your Amie clinician if maintaining muscle mass is a priority for you.

Energy and cellular health during active weight loss

Rapid weight loss — even healthy, medically supervised weight loss — places real metabolic demands on your body. Cellular energy production matters during this phase, and NAD+ (nicotinamide adenine dinucleotide) levels naturally decline with age.

Women on GLP-1 therapy sometimes notice increased fatigue, especially during the first few months of treatment. Supporting cellular energy through NAD+ therapy is something Amie clinicians may discuss as part of a broader wellness plan alongside your GLP-1 protocol.

The mental and emotional dimension

One of the most profound effects women report on GLP-1 therapy isn't a number on the scale — it's the quieting of "food noise." That constant background hum of thinking about food, planning the next meal, negotiating with cravings — GLP-1s can turn that volume way down.

This is genuinely life-changing for women who've spent years or decades in that cycle. But it also opens up questions about identity, relationship with food, and what "normal" eating looks like. These are real psychological dimensions of weight loss that deserve support — not just a prescription refill.

Ongoing clinical check-ins, dose adjustments, and the ability to talk honestly with a care team who understands your full picture aren't luxuries. They're what separates a meaningful health journey from just another thing you tried.

How to Get a GLP-1 Prescription as a Woman in 2024

Who qualifies for GLP-1 therapy?

General clinical criteria for GLP-1 prescribing include a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition (such as hypertension, type 2 diabetes, dyslipidemia, or obstructive sleep apnea).

For women specifically, conditions like PCOS (polycystic ovary syndrome), insulin resistance, and metabolic changes during perimenopause or menopause may strengthen the clinical case for GLP-1 therapy — even if BMI alone is borderline. Your clinician will assess your full health profile to determine whether you're a candidate.

The traditional path vs. telehealth

The traditional route — booking with your primary care physician or getting a referral to an endocrinologist — can mean weeks or months of wait times, insurance pre-authorization battles, and appointments with providers who may have limited experience with GLP-1 prescribing for weight management (especially for women).

Telehealth offers a faster, more direct path: clinician-guided intake, medical review, prescribing (when appropriate), and medication delivered to your door. The key is choosing a telehealth provider with actual clinical rigor — licensed prescribers, ongoing monitoring, and a care model that doesn't just hand you a prescription and disappear.

How Amie's GLP-1 program works

Amie's process is straightforward:

1. Online health assessment — you'll answer detailed questions about your health history, goals, and current medications
2. Clinician review — a licensed Amie clinician reviews your profile and determines whether GLP-1 therapy is appropriate for you
3. Prescription & delivery — if prescribed, compounded semaglutide ships directly to you from a licensed pharmacy
4. Ongoing care — regular check-ins, dose adjustments, side effect management, and the option to layer in complementary treatments as your journey evolves

"Compounded" simply means the medication is prepared by a licensed compounding pharmacy using the same active ingredient (semaglutide) in a formulation tailored to clinical specifications. It's a legal, regulated option that makes GLP-1 therapy accessible to women who can't get brand-name versions due to cost or supply shortages.

Curious what the full experience looks like? Read real member perspectives in our piece on what the Amie experience is really like.

Frequently Asked Questions

What is the most effective GLP-1 medication for weight loss in women?

Based on clinical trial data, tirzepatide (Zepbound®) has shown the highest average weight loss — approximately 20.9% of body weight at the 15mg dose in the SURMOUNT-1 trial. Semaglutide (Wegovy®) demonstrated approximately 14.9% average weight loss in the STEP 1 trial. However, the most effective medication for any individual woman depends on her health profile, tolerability, access, and her clinician's recommendation. Higher trial averages don't automatically mean a drug is the right fit for every patient.

Can women use GLP-1 medications during perimenopause or menopause?

Yes. There is growing clinical interest in GLP-1 medications for women during hormonal transitions, when declining estrogen levels drive metabolic changes that promote visceral fat accumulation and insulin resistance. GLP-1 therapy addresses appetite regulation and metabolic function — two areas directly affected by perimenopause and menopause. A clinician experienced in women's health can help determine whether a GLP-1 medication is appropriate for your specific situation.

What's the difference between brand-name semaglutide and compounded semaglutide?

Brand-name semaglutide (Wegovy® or Ozempic®) is manufactured by Novo Nordisk. Compounded semaglutide uses the same active ingredient but is prepared by a licensed compounding pharmacy, often at a lower cost and with greater availability. Compounded medications are legally available when prescribed by a licensed clinician and dispensed by a qualifying pharmacy. Amie prescribes compounded semaglutide through licensed 503A and 503B compounding pharmacies.

How long does it take to see results on a GLP-1 medication?

Most women notice reduced appetite and early changes within the first 4–6 weeks, though significant weight loss typically becomes measurable around the 8–12 week mark as doses are titrated upward. Clinical trials measured outcomes at 68–72 weeks, and the full effect of these medications unfolds over months, not days. Patience during the titration phase — when doses are intentionally kept low to minimize side effects — is a normal and expected part of the process.

Are there side effects of GLP-1 medications that are more common in women?

The most common side effects across all patients are gastrointestinal: nausea, constipation, diarrhea, and reduced appetite. Some clinical observations and real-world reports suggest women may experience more pronounced nausea and fatigue, particularly during dose titration. Hair thinning (telogen effluvium) — a temporary condition associated with rapid weight loss rather than the medication itself — has also been reported by some women. These side effects are typically manageable and often improve over time with proper clinical guidance.

Do I need to diet and exercise while on a GLP-1 medication?

GLP-1 medications are most effective when combined with lifestyle habits that support long-term health — particularly adequate protein intake, regular strength training, quality sleep, and hydration. You don't need to follow a restrictive diet, but being intentional about nutrition helps preserve lean muscle mass and supports your metabolism during active weight loss. Your Amie clinician can help you build a realistic plan that works with your life.

How do I know if I qualify for a GLP-1 prescription?

General clinical criteria include a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition. Women with PCOS, insulin resistance, or menopausal metabolic changes may also be candidates. The only way to know for certain is to complete a clinical assessment with a licensed provider. Amie's online intake takes about 10 minutes and is reviewed by a licensed clinician who will determine whether GLP-1 therapy is appropriate for you.

GLP-1Weight LossMetabolic HealthTreatments

Share

Written by

Dr. Sarah Mitchell, MD

MD

Dr. Kim combines conventional medicine with holistic approaches to women's health. She specializes in menopause management, hormone balance, and longevity medicine.

Medically Reviewed by

Dr. Sarah Mitchell, MD

MD

Last reviewed: March 23, 2026

NPI: 1679815096